Life Technologies granted Suzhou Ribo Life Sciences exclusive rights to use Invivofectamine Rx delivery technology to develop small interfering RNA (siRNA) therapeutics in China

Life Technologies Corp.

U.S. / Tools, Services, and Manufacturing

$12,756.1m on 06/21/2013 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Suzhou Ribo Life Science Co. Ltd.

China / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced